Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Bioverge
AddedFeb 13, 2024
UpdatedJul 16, 2026
Bioverge

Bioverge

Operating

Bioverge, Inc.: A US-based venture capital firm specializing in emerging healthcare startups.

Location
San Francisco, CA, US
Founded
2016
Firm
Compare
Portfolio
Fundraising
Employees
Website

Investments

Modulo Bio
Modulo Bio

Total Raised

$8M

Rounds

1

Seed$8MJune 2023
JelikaLite
JelikaLite

Total Raised

$408.7k

Rounds

4

SeedDecember 2022
Eigen Therapeutics
Eigen Therapeutics

Total Raised

$7M

Rounds

2

Seed$7MDecember 2022
SeedFebruary 2022
GigaMune
GigaMune

Total Raised

$300k

Rounds

4

SeedNovember 2022
Notable Labs
Notable Labs
Public

Total Raised

$55M

Rounds

9

Series BJuly 2022
Foresight Mental Health
Foresight Mental Health

Rounds

7

Series CJune 2022
Aspen Neuroscience
Aspen Neuroscience

Total Raised

$264M

Rounds

4

Series B$147.5MMay 2022
Octant
Octant

Total Raised

$115M

Rounds

3

Series B$80MApril 2022
Alto Neuroscience
Alto Neuroscience

Total Raised

$239.3M

Rounds

10

Series BMarch 2022
Bionaut Labs
Bionaut Labs

Total Raised

$63.2M

Rounds

5

Series BMarch 2022
Ochre Bio
Ochre Bio

Total Raised

$39.8M

Rounds

4

Series ADecember 2021
NutriSense
NutriSense

Total Raised

$31.4M

Rounds

7

Seed$3.8MSeptember 2021
Biorosa Technologies
Biorosa Technologies

Total Raised

$745k

Rounds

8

SeedJuly 2021
Enveda Biosciences
Enveda Biosciences

Total Raised

$174.9M

Rounds

7

Series AJune 2021
Juno Diagnostics
Juno Diagnostics

Total Raised

$25M

Rounds

3

Series AMay 2021
Series A$25MMay 2021
Hepatx
Hepatx

Total Raised

$2.1M

Rounds

4

SeedMay 2021
Elucid Bioimaging
Elucid Bioimaging

Total Raised

$129.7M

Rounds

9

Series A$10MMay 2021
Ancilia Biosciences
Ancilia Biosciences

Total Raised

$1M

Rounds

4

SeedDecember 2020
Repair Biotechnologies
Repair Biotechnologies

Total Raised

$11M

Rounds

5

SeedSeptember 2020
Pragma Biosciences
Pragma Biosciences

Total Raised

$14.5M

Rounds

7

SeedJune 2020
Contraline
Contraline
Series A

Total Raised

$24.6M

Rounds

10

Series AApril 2020
Rockstep Solutions
Rockstep Solutions

Total Raised

$14.2M

Rounds

14

SeedApril 2020
Excision BioTherapeutics
Excision BioTherapeutics

Total Raised

$77.6M

Rounds

8

SeedMarch 2020